Filters

Xuanxi Huang

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Plos One|January 2, 2024
GAN-based medical image small region forgery detection via a two-stage cascade frameworkJianyi Zhang, Xuanxi Huang, Yaqi Liu, et al.
Discover Oncology|March 24, 2025
WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targetsKe Liu, Jiannan Yu, Xuanxi Huang, et al.
Frontiers in Pharmacology|May 25, 2026
Clinical experience with eravacycline-based combination therapy for carbapenem-resistant Acinetobacter baumannii pneumonia: a prospective observational case seriesYing Xiao, Yu Cheng, Xiaohong Xu, et al.
BMC Infectious Diseases|September 27, 2025
The relationship between the alveolar epithelial lining fluid concentration of intravenous plus inhaled polymyxin B and clinical efficacy in patients with pneumonia caused by carbapenem-resistant gram-negative bacilli: a prospective cohort studyLili Zhou, Danjie Wang, Xueyong Li, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2025
Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteriaXueyong Li, Lili Zhou, Danjie Wang, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Plos One|January 2, 2024
GAN-based medical image small region forgery detection via a two-stage cascade frameworkJianyi Zhang, Xuanxi Huang, Yaqi Liu, et al.
Discover Oncology|March 24, 2025
WGCNA and ferroptosis genes in OSCC: unraveling prognostic biomarkers and therapeutic targetsKe Liu, Jiannan Yu, Xuanxi Huang, et al.
Frontiers in Pharmacology|May 25, 2026
Clinical experience with eravacycline-based combination therapy for carbapenem-resistant Acinetobacter baumannii pneumonia: a prospective observational case seriesYing Xiao, Yu Cheng, Xiaohong Xu, et al.
BMC Infectious Diseases|September 27, 2025
The relationship between the alveolar epithelial lining fluid concentration of intravenous plus inhaled polymyxin B and clinical efficacy in patients with pneumonia caused by carbapenem-resistant gram-negative bacilli: a prospective cohort studyLili Zhou, Danjie Wang, Xueyong Li, et al.
Antimicrobial Agents and Chemotherapy|April 16, 2025
Population pharmacokinetics study on nebulized and intravenous administration of polymyxin B in patients with pneumonia caused by multidrug-resistant gram-negative bacteriaXueyong Li, Lili Zhou, Danjie Wang, et al.
Pageof 1
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us